Reno-protective effects of perioperative dexmedetomidine in kidney transplantation: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND AND OBJECTIVE: There is currently no FDA-approved medical therapy for delayed graft function (DGF). Dexmedetomidine (DEX) has multiple reno-protective effects preventing ischemic reperfusion injury, DGF, and acute kidney injury. Therefore, we aimed to evaluate the reno-protective effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuelazm, Mohamed T., Ghanem, Ahmed, Johanis, Amit, Mahmoud, Abdelrahman, Hassan, Abdul Rhman, Katamesh, Basant E., Amin, Mostafa Atef, Abdelazeem, Basel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Nephrology - Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499682/
https://www.ncbi.nlm.nih.gov/pubmed/36997837
http://dx.doi.org/10.1007/s11255-023-03568-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499682/
https://www.ncbi.nlm.nih.gov/pubmed/36997837
http://dx.doi.org/10.1007/s11255-023-03568-3

Ejemplares similares